Contact Us


    Your Name (required)

    Your Email (required)

    Your Phone (required)

    Subject

    Interested In... (required)

    Your Message

    Advance – The Official Newsletter Of WDSrx (2nd Edition Q4 2016)

    Advance is the official newsletter of WDSrx - Woodfield Distribution, LLC

    front-page

    Leadership Letter

    Adam Runsdorf, President

    The pharmaceutical Third Party Logistics industry is undergoing significant change. The way we choose to address these changes is the difference between facing challenges or creating opportunities.

    This issue of Advance focuses on our plans to comply with new rules that are part of the Drug Supply Chain and Security Act, or DSCSA.  The law, signed in 2014, requires that all prescription drug products down to the smallest saleable unit (SSU) be electronically tracked at every stage within the supply chain. The deadline for 3PL providers including WDSrx to complete the “Track and Trace” requirement is November, 2017.  The term used to enable “Track and Trace” capability to the smallest unit is called Serialization.  We are working with three firms to complete our serialization strategy by March 2017, well ahead of the deadline date.

    WDSrx is investing significant capital to upgrade our systems, equipment and procedures.

    The project requires upgrades to warehouse technology, computer systems and packaging and labeling equipment.  New Standard Operating Procedures (SOPs) must be written and new training sessions scheduled to comply with the law.

    Our ability to pro-actively manage change instills confidence in our existing clients and promotes our business favorably with prospective clients.  Every challenge you face can be viewed from several angles.  Try turning challenges into opportunities for successful outcomes.

    I hope that you enjoy reading Advance.

    I wish you and yours a healthy, happy holiday season.

    Adam

    Adam-Bio-Photo

     

    For further information contact WDSrx at info@wdsrx.com or (561) 998-3885.

    Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.